Latest EQL Pharma News & Updates

See the latest news and media coverage for EQL Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

EQL Pharma

Generic and specialty pharmaceutical company

eqlpharma.com

Headquarters: Sweden
Company type: Public company
Number of employees: 50–59
Industry: Pharmaceuticals

Last updated August 7

Latest news about EQL Pharma

In short: EQL Pharma reported a flat Q1 with a SEK 20 million inventory write-down and continued European expansion.

Company announcements

August 7 EQL Pharma

EQL Pharma reports weak Q1 with inventory write-downs

Sales unchanged at 106.9 MSEK, gross margin fell to 17% after write-downs of 20 MSEK. Two products were launched, new CSCO appointed.

July 24 EQL Pharma

EQL Pharma publishes annual report for 2025/2026

The annual report is available on the website and contains financial information for the fiscal year.

May 8 EQL Pharma

EQL Pharma reports year-end results for April 2025–March 2026

Sales increased 6% to 120.2 MSEK in Q4, but margins fell due to one-off costs and logistics issues. Forecast for 2026/27 is 15% growth.

February 3 EQL Pharma

EQL Pharma's CEO presents Q3 FY 2025/26 results

Media coverage

August 6 AffärsVärlden

EQL Pharma posts a loss: "A tough period" | Affärsvärlden

The generics company EQL Pharma reports a slight decrease in revenue in the first quarter compared with the same period last year.

July 10 Dagens industri

EQL Pharma under investigation for insider trading

An employee at the pharmaceutical company EQL Pharma is suspected of insider trading, confirms the company's CEO Axel Schörling to Di. A former employee is also suspected.

May 9 The Globe and Mail

EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline

EQL Pharma reported record quarterly sales of SEK 120.2 million for the fourth quarter, up 6% year-on-year, but profitability weakened as gross margin fell to...

May 8 Finanznachrichten

EQL Pharma AB: Year-end Report April 2025 - March 2026

During the quarter, sales rose to SEK 120.2 million, an increase of 6% from SEK 113.3 million in the previous year. Growth for next year...

Never miss news about EQL Pharma

Track EQL Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

EQL Pharma competitors & trending companies

Browse news for competitors to EQL Pharma and other trending companies.